68 related articles for article (PubMed ID: 12537770)
1. Expression and regulation of the transcriptional repressor ZNF43 in Ewing sarcoma cells.
González-Lamuño D; Loukili N; García-Fuentes M; Thomson TM
Pediatr Pathol Mol Med; 2002; 21(6):531-40. PubMed ID: 12537770
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
Lee J; Rhee BK; Bae GY; Han YM; Kim J
Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
[TBL] [Abstract][Full Text] [Related]
5. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
6. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
8. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
[TBL] [Abstract][Full Text] [Related]
9. Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cells.
Berry PA; Zhang YF; Carter ND; Jeffery S; Burchill SA
Med Pediatr Oncol; 2001 Jan; 36(1):142-6. PubMed ID: 11464869
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell features of Ewing tumors.
Tirode F; Laud-Duval K; Prieur A; Delorme B; Charbord P; Delattre O
Cancer Cell; 2007 May; 11(5):421-9. PubMed ID: 17482132
[TBL] [Abstract][Full Text] [Related]
11. Response of Ewing tumor cells to forced and activated p53 expression.
Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
[TBL] [Abstract][Full Text] [Related]
12. The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells.
Amsellem V; Kryszke MH; Hervy M; Subra F; Athman R; Leh H; Brachet-Ducos C; Auclair C
Exp Cell Res; 2005 Apr; 304(2):443-56. PubMed ID: 15748890
[TBL] [Abstract][Full Text] [Related]
13. C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions.
Scotlandi K; Manara MC; Strammiello R; Landuzzi L; Benini S; Perdichizzi S; Serra M; Astolfi A; Nicoletti G; Lollini PL; Bertoni F; Nanni P; Picci P
J Clin Oncol; 2003 May; 21(10):1952-60. PubMed ID: 12743148
[TBL] [Abstract][Full Text] [Related]
14. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic fusion protein EWS/NOR-1 induces transformation of CFK2 chondrogenic cells.
Filion C; Labelle Y
Exp Cell Res; 2004 Jul; 297(2):585-92. PubMed ID: 15212958
[TBL] [Abstract][Full Text] [Related]
16. Activation of transcriptional activities of AP1 and SRE by a novel zinc finger protein ZNF445.
Luo K; Yuan J; Shan Y; Li J; Xu M; Cui Y; Tang W; Wan B; Zhang N; Wu Y; Yu L
Gene; 2006 Feb; 367():89-100. PubMed ID: 16368201
[TBL] [Abstract][Full Text] [Related]
17. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
[TBL] [Abstract][Full Text] [Related]
18. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
19. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-kit in Ewing family of tumors: a comparison of different immunohistochemical protocols.
Ahmed A; Gilbert-Barness E; Lacson A
Pediatr Dev Pathol; 2004; 7(4):342-7. PubMed ID: 15383930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
